Global Thrombin (Human) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Thrombin (Human) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Thrombin (Human) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Thrombin (Human) market is projected to reach US$ 704.7 million in 2034, increasing from US$ 565 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2034. Demand from Biotechnology and Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Thrombin (Human) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Thrombin (Human) key manufacturers include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL and Bayer, etc. Baxter, AMRESCO Inc, BD Biosciences are top 3 players and held % sales share in total in 2022.
Thrombin (Human) can be divided into 500IU/Vial, 1000IU/Vial and 2500IU/Vial,, etc. 500IU/Vial is the mainstream product in the market, accounting for % sales share globally in 2022.
Thrombin (Human) is widely used in various fields, such as Biotechnology, Medicine, Microbiology and Others, etc. Biotechnology provides greatest supports to the Thrombin (Human) industry development. In 2022, global % sales of Thrombin (Human) went into Biotechnology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thrombin (Human) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Segment by Type
500IU/Vial
1000IU/Vial
2500IU/Vial
Biotechnology
Medicine
Microbiology
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Thrombin (Human) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Thrombin (Human), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Thrombin (Human) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Thrombin (Human) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Thrombin (Human) introduction, etc. Thrombin (Human) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Thrombin (Human) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Thrombin (Human) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Thrombin (Human) key manufacturers include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL and Bayer, etc. Baxter, AMRESCO Inc, BD Biosciences are top 3 players and held % sales share in total in 2022.
Thrombin (Human) can be divided into 500IU/Vial, 1000IU/Vial and 2500IU/Vial,, etc. 500IU/Vial is the mainstream product in the market, accounting for % sales share globally in 2022.
Thrombin (Human) is widely used in various fields, such as Biotechnology, Medicine, Microbiology and Others, etc. Biotechnology provides greatest supports to the Thrombin (Human) industry development. In 2022, global % sales of Thrombin (Human) went into Biotechnology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thrombin (Human) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Segment by Type
500IU/Vial
1000IU/Vial
2500IU/Vial
Segment by Application
Biotechnology
Medicine
Microbiology
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Thrombin (Human) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Thrombin (Human), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Thrombin (Human) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Thrombin (Human) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Thrombin (Human) introduction, etc. Thrombin (Human) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Thrombin (Human) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.